Results 81 to 90 of about 5,052,436 (221)

TIMI flow grade 3.

, 2022
Group 1: Thrombolytic agent; Group 2: Glycoprotein IIb/IIIa inhibitors (GPI); Group 3: GPI plus aspiration thrombectomy.
Amr Omar (10063676), Rasha Kaddoura (12506936), Fahad Al-Kindi (12506939), Abdul Rahman Arabi (12506942), Mohamed Izham Mohamed Ibrahim (10221287), Daoud Al-Badriyeh (832403)   +5 more
core   +1 more source

In Vivo Partial Cell Reprogramming With Yamanaka Factors Reduced Ischemic Brain Damage in Aging Mice

Aging Cell, Volume 25, Issue 11, November 2026.
Short‐term cyclic partial reprogramming with Yamanaka factors protects aged mice from ischemic brain injury, preserving cognitive function, myelin integrity, and neuronal density, supporting partial reprogramming as a promising neuroprotective intervention in aging.
Paula R. Mallavibarrena, Gerardo Martín‐López, Jorge Rodríguez‐Morales, Jesús Ávila, Félix Hernández, María José Pérez‐Álvarez   +5 more
wiley   +1 more source

Cloning and expression of a new recombinant thrombolytic and anthithrombotic agent - a staphylokinase variant [PDF]

, 2009
To develop a more potent antithrombin agent with thrombolytic and antiplatelet properties, a new staphylokinase (SAK) variant was constructed. The kringle 2 domain (K2) of tissue type-plasminogen activator (t-PA) containing a fibrin-specific binding site
Pietras, Tadeusz, Brown, George, Makandjou-Ola, Eusebio, Chabielska, Ewa, Bartkowiak, Jacek, Kowalski, Michał, Bieniasz, Magdalena, Szemraj, Zofia, Szemraj, Janusz, Oszajca, Katarzyna   +9 more
core  

Pharmacological modification of the vascular response to systemically administered thrombolytic enzymes (CA-7)

, 1969
Thrombolytic enzymes are recognized as potent activators of the vasodepressor plasma kinins. In an attempt to modify the vascular response to systemic administration of such enzymes, the fungal protease CA-7 was used as a model.
Sandra L. Miller, Harvey J. Freedman, Walter H. E. Roschlau   +2 more
core   +1 more source

Thrombolytic, Membrane Stabilizing, Analgesic activities along with Phytochemical Screening of the Methanolic Extract of Xanthium indicum Koenig Fruits [PDF]

, 2018
Objective: This study aimed to assess the thrombolytic, membrane stabilizing, and analgesic activities of the methanolic extract of the fruits of Xanthium indicum Koenig and undertook a phytochemical screening.Material and Methods: A qualitative analysis
Rubaiya Anjum, Monir Hossain, Saddam Hussain, Mamun Or Rashid, Sharmin Akter   +4 more
core   +1 more source

Clinical profile and mortality of ST-Segment elevation myocardial- infarction patients receiving thrombolytic -Therapy in the Middle East

Heart Views, 2012
Objective: Little is known about thrombolytic therapy patterns in patients with ST-elevation myocardial infarction (STEMI) in the Middle East. The objective of this study was to evaluate the clinical profile and mortality of STEMI patients who arrived in
Prashanth Panduranga, Ibrahim Al-Zakwani, Kadhim Sulaiman, Khalid Al-Habib, Jassim Al Suwaidi, Ahmed Al-Motarreb, Alawi Alsheikh-Ali, Shukri Al Saif, Hussam Al Faleh, Wael Almahmeed, Nidal Asaad, Haitham Amin, Jawad Al-Lawati, Ahmad Hersi   +13 more
doaj   +1 more source

Initiation of SGLT2 Inhibitors Versus DPP‐4 Inhibitors in Metformin Users and Risk of Incident Depression: A Nationwide, Claims‐Based Active‐Comparator New‐User Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10765-10779, November 2026.
ABSTRACT Aims To examine the association between initiation of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors and risk of incident depression compared with dipeptidyl peptidase‐4 (DPP‐4) inhibitors among adults with newly diagnosed Type 2 diabetes receiving metformin.
Sangwoo Park, Seogsong Jeong, Hye Jun Kim, Dae Ho Lee, Soo Jung Choi, Sang Min Park   +5 more
wiley   +1 more source

Major adverse cardiovascular events.

, 2022
Group 1: Thrombolytic agent; Group 2: Glycoprotein IIb/IIIa inhibitors (GPI); Group 3: GPI plus aspiration thrombectomy.
Amr Omar (10063676), Rasha Kaddoura (12506936), Fahad Al-Kindi (12506939), Abdul Rahman Arabi (12506942), Mohamed Izham Mohamed Ibrahim (10221287), Daoud Al-Badriyeh (832403)   +5 more
core   +1 more source

Effect of Fagonia Arabica (Dhamasa) on in vitro thrombolysis

BMC Complementary and Alternative Medicine, 2007
Background Atherothrombotic diseases such as myocardial or cerebral infarction are serious consequences of the thrombus formed in blood vessels. Thrombolytic agents are used to dissolve the already formed clots in the blood vessels; however, these drugs ...
Taori Girdhar M, Purohit Hemant J, Deopujari Jayant Y, Kashyap Rajpal, Prasad Sweta, Daginawala Hatim F   +5 more
doaj   +1 more source

Acrylonitrile adducts: design, synthesis and biological evaluation as antimicrobial, haemolytic and thrombolytic agent. [PDF]

Sci Rep, 2023
Das P, Devi N, Gaur N, Goswami S, Dutta D, Dubey R, Puzari A.   +6 more
europepmc   +1 more source